Inventor · disambiguated record
Yuelian Xu
Also filed as: XU YUELIAN
14 granted patents·16 pending applications·17 citations·filing 2003–2023
87Inventor score
Files withNEUROGEN CORP8EXITHERA PHARMACEUTICALS INC6XU YUELIAN5ZHEJIANG KANGBEIDE SMART FURNISHINGS CO LTD4LIGAND PHARM INC2
Top patents by PatentIndex Score
30 records- 0190US11807650B2NMDA receptor modulators and uses thereofNOVARTIS AG·Filed 2022·Granted Nov 7, 2023·1 cites·17 claims
- 0287US11274107B2NMDA receptor modulators and uses thereofCADENT THERAPEUTICS INC·Filed 2017·Granted Mar 15, 2022·3 cites·20 claims
- 0381US12358929B2NMDA receptor modulators and uses thereofNOVARTIS AG·Filed 2023·Granted Jul 15, 2025·0 cites·14 claims
- 0476USD1009833SRemote controlZHEJIANG KANGBEIDE SMART FURNISHINGS CO LTD·Filed 2021·Granted Jan 2, 2024·6 cites·1 claims
- 0575US7851474B2Dipiperazinyl ketones and related analoguesNEUROGEN CORP·Filed 2006·Granted Dec 14, 2010·3 cites·22 claims
- 0669US12152014B2Therapeutic compounds and compositionsEXLTHERA PHARMACEUTICALS INC·Filed 2023·Granted Nov 26, 2024·0 cites·18 claims
- 0769US2023270731A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0865US2021361634A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0963US7271170B2Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligandsNEUROGEN CORP·Filed 2004·Granted Sep 18, 2007·1 cites·190 claims
- 1062US6951864B24-imidazol-1-ylmethyl-pyrimidine derivativesNEUROGEN CORP·Filed 2003·Granted Oct 4, 2005·1 cites·24 claims
- 1159US11691962B2Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2020·Granted Jul 4, 2023·0 cites·14 claims
- 1256US2008139580A1Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligandsNEUROGEN CORP·Filed 2007·Application pending·0 cites
- 1351USD1012875SRemote controlZHEJIANG KANGBEIDE SMART FURNISHINGS CO LTD·Filed 2021·Granted Jan 30, 2024·1 cites·1 claims
- 1451USD997915SRemote controlZHEJIANG KANGBEIDE SMART FURNISHINGS CO LTD·Filed 2021·Granted Sep 5, 2023·1 cites·1 claims
- 1549US2021253550A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1649US2010317679A1Substituted aryl-fused spirocyclic aminesLIGAND PHARM INC·Filed 2008·Application pending·0 cites
- 1749US2021261524A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1849US2011002855A1Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analoguesNEUROGEN CORP·Filed 2008·Application pending·0 cites
- 1946US2008004269A1Pyrazolylmethy Heteroaryl DerivativesXU YUELIAN·Filed 2005·Application pending·0 cites
- 2046US2008247964A1Substituted azaspiro derivativesXU YUELIAN·Filed 2007·Application pending·0 cites
- 2146US2008051387A1Tetrahydropyrido[3,4-d]pyrimidines and related analoguesXU YUELIAN·Filed 2007·Application pending·0 cites
- 2245US7351826B2Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compoundsNEUROGEN CORP·Filed 2004·Granted Apr 1, 2008·0 cites·23 claims
- 2345US7122546B2Imidazol-1-ylmethyl pyridazine derivativesNEUROGEN CORP·Filed 2003·Granted Oct 17, 2006·0 cites·28 claims
- 2445US2008167324A1Thiazolymethyl and Oxazolylmethyl Heteroaryl DerivativesXU YUELIAN·Filed 2006·Application pending·0 cites
- 2544US2006247245A1Substituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligandsXU YUELIAN·Filed 2004·Application pending·0 cites
- 2644US2011082130A1Piperazinyl oxoalkyl tetrahydroisoquinolines and related analoguesLIGAND PHARM INC·Filed 2010·Application pending·0 cites
- 2744US2005148601A1Neurokinin-3 receptor modulators: diaryl imidazole derivativesFiled 2004·Application pending·0 cites
- 2842US2009023737A1Imidazo-Pyridazines, Triazolo-Pyridazines and Related Benzodiazepine Receptor LigandsNEUROGEN CORP·Filed 2005·Application pending·0 cites
- 2938USD1018124SBed leverZHEJIANG KANGBEIDE SMART FURNISHINGS CO LTD·Filed 2021·Granted Mar 19, 2024·0 cites·1 claims
- 3038US2019315711A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yuelian Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →